These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6085390)

  • 1. Effects of nitrendipine and other calcium antagonists on glucose metabolism in man.
    Trost BN; Weidmann P
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S986-95. PubMed ID: 6085390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antihypertensive therapy on glucose tolerance: focus on calcium antagonists.
    Hedner T; Samuelsson O; Lindholm L
    J Intern Med Suppl; 1991; 735():101-11. PubMed ID: 2043219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose metabolism and calcium antagonists.
    Trost BN
    Horm Metab Res Suppl; 1990; 22():48-56. PubMed ID: 2202627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of calcium antagonists on glucose homeostasis and serum lipids in non-diabetic and diabetic subjects: a review.
    Trost BN; Weidmann P
    J Hypertens Suppl; 1987 Dec; 5(4):S81-104. PubMed ID: 3326922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nifedipine and nitrendipine on insulin secretion in obese patients.
    Valensi P; Uzzan B; Attali JR; Perret G
    J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S91-3. PubMed ID: 1723467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The natriuresis following oral administration of the calcium antagonists--nifedipine and nitrendipine.
    Ene MD; Williamson PJ; Roberts CJ; Waddell G
    Br J Clin Pharmacol; 1985 Apr; 19(4):423-7. PubMed ID: 3158325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitrendipine and other calcium entry blockers (calcium antagonists) in hypertension.
    Kazda S; Garthoff B; Knorr A
    Fed Proc; 1983 Feb; 42(2):196-200. PubMed ID: 6822291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of nifedipine and nitrendipine on insulin release in non-diabetic obese patients: a double-blind, placebo-controlled study.
    Valensi P; Uzzan B; Vassy R; Attali JR; Perret G
    Methods Find Exp Clin Pharmacol; 1991 Oct; 13(8):557-63. PubMed ID: 1956211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium channel blockade with nitrendipine. Effects on sodium homeostasis, the renin-angiotensin system, and the sympathetic nervous system in humans.
    Luft FC; Aronoff GR; Sloan RS; Fineberg NS; Weinberger MH
    Hypertension; 1985; 7(3 Pt 1):438-42. PubMed ID: 3158605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors involved in the antihypertensive action of calcium antagonists.
    Garthoff B; Kazda S; Knorr A; Thomas G
    Hypertension; 1983; 5(4 Pt 2):II34-8. PubMed ID: 6345375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium antagonists for antihypertensive baseline therapy. First International Nitrendipine Symposium. Interlaken, April 13-14, 1984.
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S929-1113. PubMed ID: 6085378
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of the acute hemodynamic effects of nifedipine with nitrendipine and a study of the electrophysiological effects of nitrendipine in man.
    Rutsch W; Schmutzler H
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1011-5. PubMed ID: 6085358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of alpha-adrenergic blockers, ACE inhibitors, and calcium channel antagonists on renal function in hypertensive non-insulin-dependent diabetic patients.
    Giordano M; Sanders LR; Castellino P; Canessa ML; DeFronzo RA
    Nephron; 1996; 72(3):447-53. PubMed ID: 8852495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug interactions with nitrendipine.
    Kirch W; Hutt HJ; Heidemann H; Rämsch K; Janisch HD; Ohnhaus EE
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S982-5. PubMed ID: 6085389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diazepam-stimulated increases in the synaptosomal uptake of 45Ca2+: reversal by dihydropyridine calcium channel antagonists.
    Mendelson WB; Skolnic P; Martin JV; Luu MD; Wagner R; Paul SM
    Eur J Pharmacol; 1984 Sep; 104(1-2):181-3. PubMed ID: 6499915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of angiotensin-converting enzyme inhibitors, Ca2+ channel antagonists, and alpha-adrenergic blockers on glucose and lipid metabolism in NIDDM patients with hypertension.
    Giordano M; Matsuda M; Sanders L; Canessa ML; DeFronzo RA
    Diabetes; 1995 Jun; 44(6):665-71. PubMed ID: 7789631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of [3H]nitrendipine binding and KCl-induced calcium uptake in rat cortical synaptosomes.
    Wei JW; Chiang DH
    Gen Pharmacol; 1985; 16(3):211-6. PubMed ID: 3160632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium antagonists and blood glucose in normal rabbits.
    Patel RB; Shah GF; Raval JD; Gandhi TP; Gilbert RN
    Arzneimittelforschung; 1987 Apr; 37(4):410-2. PubMed ID: 3300662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the calcium-channel agonist CGP 28392 on insulin secretion from isolated rat islets of Langerhans.
    Morgan NG; Short CD; Rumford GM; Montague W
    Biochem J; 1985 Nov; 231(3):629-34. PubMed ID: 2934056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of calcium antagonists on carbohydrate and lipid metabolism].
    Preobrazhenskiĭ DV; Fomichev VI; Afanas'ev AIa
    Kardiologiia; 1992 Apr; 32(4):84-9. PubMed ID: 1405247
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.